• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2005-2015 年美国全国范围内乳腺癌保乳乳房重建和乳头保留乳房切除术的模式。

National Patterns of Breast Reconstruction and Nipple-Sparing Mastectomy for Breast Cancer, 2005-2015.

机构信息

Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.

Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.

出版信息

Ann Surg Oncol. 2019 Oct;26(10):3194-3203. doi: 10.1245/s10434-019-07554-x. Epub 2019 Jul 24.

DOI:10.1245/s10434-019-07554-x
PMID:31342383
Abstract

BACKGROUND

The purpose of this study was to explore national patterns in the uptake of breast reconstruction and nipple-sparing mastectomy (NSM).

METHODS

We used the National Cancer Database to identify all women who underwent mastectomy for stage 0-III breast cancer between 2005-2015. Multivariable logistic regression was used to determine factors associated with receipt of reconstruction, with subset analyses performed to determine trends and predictors of NSM in those who underwent mastectomy with reconstruction.

RESULTS

Our cohort consisted of 395,815 women, 238,568 (60.3%) who underwent mastectomy alone and 157,247 (39.7%) who underwent mastectomy followed by reconstruction. The use of breast reconstruction increased from 22.3% of mastectomy cases in 2005 to 49.7% of mastectomy cases in 2015 (odds ratio [OR] 9.7, 95% confidence interval [CI] 7.3-12.8). Among those receiving reconstruction, the use of NSM increased from 1.7% in 2005 to 14.3% in 2015 (OR 9.4, 95% CI 7.1-12.5), with increased utilization among those with early-stage and locally advanced disease, such that by 2015, NSM was performed in 15.3% of mastectomies with reconstruction for DCIS, 14.3% of mastectomies with reconstruction for stage I-II breast cancer, and 10.7% of mastectomies with reconstruction for stage III breast cancer. Factors strongly predicting receipt of NSM included age < 45 years, smaller clinical tumor size, clinically node negative disease, use of neoadjuvant therapy, and facility type.

CONCLUSIONS

There has been a dramatic increase in the use of breast reconstruction and NSM between 2005-2015. Further prospective studies evaluating oncologic outcomes of NSM in locally advanced breast cancer are warranted.

摘要

背景

本研究旨在探讨全美范围内乳房重建和保留乳头乳晕的乳房切除术(NSM)的应用模式。

方法

我们使用国家癌症数据库,确定了 2005 年至 2015 年间所有接受 0-III 期乳腺癌乳房切除术的女性。采用多变量逻辑回归分析确定接受重建的相关因素,并进行亚组分析,以确定接受重建的乳房切除术患者中 NSM 的趋势和预测因素。

结果

我们的队列包括 395815 名女性,其中 238568 名(60.3%)接受单纯乳房切除术,157247 名(39.7%)接受乳房切除术加重建。乳房重建的使用率从 2005 年的 22.3%上升到 2015 年的 49.7%(优势比 [OR] 9.7,95%置信区间 [CI] 7.3-12.8)。在接受重建的患者中,NSM 的使用率从 2005 年的 1.7%上升到 2015 年的 14.3%(OR 9.4,95% CI 7.1-12.5),在早期和局部晚期疾病患者中使用率更高,以至于到 2015 年,保乳术的 DCIS 重建中 NSM 的使用率为 15.3%,I 期-II 期乳腺癌重建中为 14.3%,III 期乳腺癌重建中为 10.7%。强烈预测 NSM 接受率的因素包括年龄<45 岁、较小的临床肿瘤大小、临床无淋巴结转移疾病、使用新辅助治疗和医疗机构类型。

结论

2005 年至 2015 年期间,乳房重建和 NSM 的使用率大幅上升。需要进一步进行前瞻性研究,评估局部晚期乳腺癌中 NSM 的肿瘤学结果。

相似文献

1
National Patterns of Breast Reconstruction and Nipple-Sparing Mastectomy for Breast Cancer, 2005-2015.2005-2015 年美国全国范围内乳腺癌保乳乳房重建和乳头保留乳房切除术的模式。
Ann Surg Oncol. 2019 Oct;26(10):3194-3203. doi: 10.1245/s10434-019-07554-x. Epub 2019 Jul 24.
2
Evaluation of Local Oncologic Safety in Nipple-Areola Complex-sparing Mastectomy After Primary Chemotherapy: A Propensity Score-matched Study.原发性化疗后保留乳头乳晕复合体的乳房切除术中局部肿瘤学安全性的评估:一项倾向评分匹配研究
Clin Breast Cancer. 2017 Jun;17(3):219-231. doi: 10.1016/j.clbc.2016.12.003. Epub 2016 Dec 24.
3
Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.接受新辅助化疗的乳腺癌患者即刻乳房重建的肿瘤学安全性:一项匹配病例对照研究的短期结果
Clin Breast Cancer. 2017 Jun;17(3):204-210. doi: 10.1016/j.clbc.2016.10.009. Epub 2016 Oct 27.
4
Nipple-sparing mastectomy in 99 patients with a mean follow-up of 5 years.99 例患者行保留乳头乳晕的乳房切除术,平均随访 5 年。
Ann Surg Oncol. 2011 Jun;18(6):1665-70. doi: 10.1245/s10434-010-1475-4. Epub 2010 Dec 21.
5
[Breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy for breast cancer].[乳腺癌保乳皮肤或保乳乳头乳房切除术后的乳房重建]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Jul;27(7):872-5.
6
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.保留乳头的乳房切除术联合术中放疗(ELIOT):一种用于乳腺癌治疗的新型乳房切除术。
Breast Cancer Res Treat. 2006 Mar;96(1):47-51. doi: 10.1007/s10549-005-9033-7. Epub 2005 Oct 27.
7
Nipple-sparing Mastectomy for the Management of Recurrent Breast Cancer.保留乳头的乳房切除术治疗复发性乳腺癌
Clin Breast Cancer. 2017 Jul;17(4):e209-e213. doi: 10.1016/j.clbc.2016.10.011. Epub 2017 Jan 9.
8
Oncologic safety of nipple-sparing mastectomy in patients with short tumor-nipple distance.保乳手术中肿瘤-乳头距离较短患者的肿瘤学安全性。
Breast J. 2019 Jul;25(4):612-618. doi: 10.1111/tbj.13289. Epub 2019 May 13.
9
Do clinicopathological features of the cancer patient relate with nipple areolar complex necrosis in nipple-sparing mastectomy?保乳手术中乳头乳晕复合体坏死与癌症患者的临床病理特征有关吗?
Ann Surg Oncol. 2013 Mar;20(3):990-6. doi: 10.1245/s10434-012-2677-8. Epub 2012 Oct 16.
10
Positive Nipple Margins in Nipple-Sparing Mastectomies: Rates, Management, and Oncologic Safety.保乳手术中乳头切缘阳性:发生率、处理方法及肿瘤安全性。
J Am Coll Surg. 2016 Jun;222(6):1149-55. doi: 10.1016/j.jamcollsurg.2016.02.016. Epub 2016 Mar 4.

引用本文的文献

1
A protocol for three observational cohort studies evaluating adverse outcomes, excess costs and repeat procedures after surgery for breast cancer in the USA.一项针对美国乳腺癌手术后不良结局、额外费用和重复手术情况的三项观察性队列研究方案。
J Comp Eff Res. 2025 Aug;14(8):e250013. doi: 10.57264/cer-2025-0013. Epub 2025 Jul 14.
2
Individualized Analysis of Nipple-Sparing Mastectomy Versus Modified Radical Mastectomy Using Deep Learning.使用深度学习对保乳根治术与改良根治术进行个体化分析。
Cancer Innov. 2025 Mar 26;4(3):e70002. doi: 10.1002/cai2.70002. eCollection 2025 Jun.
3
ASO Author Reflections: The Age-Old Question in Nipple-Sparing Mastectomy: Is Older Age a Contraindication?
ASO作者反思:保乳乳房切除术中的古老问题:高龄是禁忌证吗?
Ann Surg Oncol. 2025 Apr;32(4):2594. doi: 10.1245/s10434-024-16864-8. Epub 2025 Jan 23.
4
The Age-Old Question in Nipple-Sparing Mastectomy: Is Older Age a Contraindication?保乳乳房切除术中的古老问题:高龄是禁忌证吗?
Ann Surg Oncol. 2025 Apr;32(4):2569-2577. doi: 10.1245/s10434-024-16741-4. Epub 2025 Jan 3.
5
Underuse of Postoperative Radiation After Nipple-Sparing Mastectomy for Standard Radiation Indications.保乳根治性乳房切除术后针对标准放疗指征的术后放疗使用不足。
Adv Radiat Oncol. 2024 Jul 14;9(9):101569. doi: 10.1016/j.adro.2024.101569. eCollection 2024 Sep.
6
Safety of Atypical Ductal Hyperplasia at the Nipple Margin in Nipple-Sparing Mastectomy.保乳手术中乳头边缘非典型导管增生的安全性
J Breast Cancer. 2024 Aug;27(4):260-269. doi: 10.4048/jbc.2024.0077. Epub 2024 Jul 16.
7
Molecular subtype and risk of local recurrence after nipple‑sparing mastectomy for breast cancer.乳腺癌保乳术后的分子亚型与局部复发风险
Oncol Lett. 2024 Jun 21;28(2):389. doi: 10.3892/ol.2024.14522. eCollection 2024 Aug.
8
ASO Author Reflections: Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.ASO作者反思:保乳乳房切除术中乳头切缘阳性:含癌或异型增生乳头的处理
Ann Surg Oncol. 2024 Aug;31(8):5211-5212. doi: 10.1245/s10434-024-15426-2. Epub 2024 May 28.
9
Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.保乳手术中乳头切缘阳性:含癌或异型增生乳头的处理
Ann Surg Oncol. 2024 Aug;31(8):5148-5156. doi: 10.1245/s10434-024-15362-1. Epub 2024 May 1.
10
Reconstruction of the human nipple-areolar complex: a tissue engineering approach.人乳头乳晕复合体的重建:一种组织工程学方法。
Front Bioeng Biotechnol. 2024 Feb 15;11:1295075. doi: 10.3389/fbioe.2023.1295075. eCollection 2023.